The browser doesnot support javascript
Print Plan Forms | Help

Medication Safety Alerts

Brintellix® Name Change

05/02/2016


On May 2, 2016, the United States Food and Drug Administration (FDA) issued a MedWatch to announce they had approved changing the name of the drug Brintellix® to Trintellix®. This was done to decrease the risk of prescribing and dispensing errors resulting from name confusion with the blood-thinning medicine Brilinta®.

Trintellix is expected to be available starting in June 2016. No other changes will be made to the label or packaging. The medicine will be exactly the same.

The FDA recommends that members should make sure they have received the correct medicine. Trintellix tablets will look the same as the Brintellix tablets. Those having any questions or concerns should talk to their doctor or pharmacist.

CVS/caremark Response: Because of the time it takes to manufacturing bottles with the new brand name, plan members may continue to see bottles labeled with the brand name Brintellix during the transition period. CVS/caremark will continue to dispense Brintellix during this transition period.

If you are currently taking Brintellix and have questions, please call your doctor or call the FDA consumer inquiry line, toll-free at 1‑888‑INFO-FDA (1‑888-463-6332) or visit their web site at www.fda.gov/Safety/.

The CVS/caremark™ app lets you manage your prescription benefits on the go. Download it now:

CVS Health LogoCVS Pharmacy LogoCVS Minute Clinic LogoCVS Specialty LogoSilverscript LogoAccordant Logo

Copyright © 2018 CVS/caremark. All rights reserved| Terms and Conditions | Privacy Policy | Accessibility | Member Rights & Responsibilities